A new research paper was published in Oncotarget entitled, "Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II–III breast cancer."
Mar 27, 2024
0
0
Exercising during pregnancy doesn't just benefit moms—it may also give their babies a head start on their heart health after birth, according to a study by researchers at The Ohio State University Wexner Medical Center.
Mar 27, 2024
0
0
When Kate Middleton, the princess of Wales, announced in March 2024 that she was receiving "preventive chemotherapy" following abdominal surgery, many wondered what that entails. Formally known as adjuvant therapy, administering ...
Mar 27, 2024
0
12
Scientists have discovered how breast cancer cells can "hibernate" to avoid treatment and "wake up" years later—causing a relapse that is more difficult to treat.
Mar 26, 2024
0
1
There is a lot going on within the field of breast cancer research. A new AI tool is trying to fine-tune the screening program, another one is helping pathologists make diagnoses. New drugs are approved. This could save more ...
Mar 22, 2024
0
3
Triple negative breast cancer is the most aggressive subtype of the disease and is notorious for a poor prognosis, but scientists are working on a breakthrough method of converting these treatment-resistant tumors into a ...
Patients with breast cancer that has started to spread to the lymph nodes in the armpit can safely avoid extensive removal of the lymph nodes if their treatment is tailored to their response to cancer-killing therapies such ...
Mar 21, 2024
0
0
An artificial intelligence (AI) breast screening solution called Mia helped doctors find an additional 12% more cancers than in routine practice, as announced today in collaboration with Kheiron Medical Technologies, NHS ...
Mar 21, 2024
0
0
Expressing or pumping breast milk is an important tool for mothers, especially those who face challenges with direct breastfeeding, but new research from Flinders University has found conflicting advice in the age of social ...
Mar 21, 2024
0
0
A new treatment approach that combines a targeted therapy drug with hormone therapy significantly increased the amount of time a person with stage 2 or 3 HR-positive, HER2-negative early breast cancer lives without the cancer ...
Mar 21, 2024
0
182
